Skip to content
EN
EN FR NL
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
    • Collaborations
      • Patient advocates
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Menu
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
    • Collaborations
      • Patient advocates
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
    • Collaborations
      • Patient advocates
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Menu
  • About
    • About BIG
    • Strategy statement
    • BIG history
    • Governance
    • Honorary President
    • BIG HQ
    • Careers
    • Annual report
    • Contact us
  • Research
    • Research principles
    • Trials and programmes
    • EU Programmes
      • TRANSBIG
      • EURECA
      • INTEGRATE
    • Achievements
    • Translational research
    • Peer-reviewed articles
  • Members & Partners
    • BIG network
    • Collaborations
      • Patient advocates
      • BIG-NCTN
      • Industry
    • Foundations
    • Our corporate partners
      • Become a corporate partner
  • News
    • Updates
    • BIG Research in Focus
    • Press Room
  • BIG against breast cancer
    • About
    • Martine Piccart
    • BIG ambassadors
    • Events
    • Donate
    • Fundraise
    • BIG Missing campaign
  • Members login
Donate
BIG Members
EN
EN FR NL

Neo-adjuvant

DECRESCENDO

ULTIMATE

LORELEI

PENELOPE-B

Exceptional Responders

NeoALTTO

Breast international group (BIG) – aisbl

Rue de bretagne 20,
1200 Brussels, Belgium
VAT BE 0468 176 240
IBAN BE08 0689 0916 0213

Facebook-f Twitter Instagram Linkedin Youtube Flickr

Navigation

  • About
  • Research
  • News
  • Support research
  • Press room
  • Contact us
  • Privacy policy
  • FAQ
AERFLABELPMSDEFVblanc

The Breast International Group is proud to adhere
to the Code of Ethics of the VEF-AERF

© 2022 All rights reserved

Breast international group (BIG) - aisbl